ArticleLeukemia2013

Sequential combination of azacitidine and lenalidomide in del(5q) higher-risk myelodysplastic syndromes or acute myeloid leukemia: a phase I study.

U Platzbecker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.